What Makes Oric Pharmaceuticals, Inc. (ORIC) a Strong Momentum Stock: Buy Now?

Company Overview - Oric Pharmaceuticals, Inc. (ORIC) currently holds a Momentum Style Score of A, indicating strong potential for momentum investing [3] - The company has a Zacks Rank of 2 (Buy), suggesting favorable market performance expectations [4] Performance Metrics - Over the past week, ORIC shares have increased by 14.08%, outperforming the Zacks Medical - Biomedical and Genetics industry, which rose by 5.43% [6] - In a longer time frame, ORIC's monthly price change is 104.01%, significantly higher than the industry's 7.54% [6] - Over the last quarter, ORIC shares have risen by 28.76%, and over the past year, they are up 25.91%, while the S&P 500 has only moved 8.33% and 12.92%, respectively [7] Trading Volume - ORIC's average 20-day trading volume is 1,988,020 shares, which serves as a bullish indicator when combined with rising stock prices [8] Earnings Outlook - In the past two months, 5 earnings estimates for ORIC have been revised upwards, while only 1 has been revised downwards, leading to an increase in the consensus estimate from -$2.06 to -$1.75 [10] - For the next fiscal year, 3 estimates have moved upwards, with 1 downward revision during the same period [10] Conclusion - Given the strong performance metrics and positive earnings outlook, ORIC is positioned as a promising investment opportunity with a Momentum Score of A [12]